Matteo Pedrazzini

7PUBLICATIONS
72CO-AUTHORS
Molecular targetsHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 22, 2026
Targeting trafficking defects in long QT syndrome type 2: a phase 2 clinical study with patient-specific cellular validation.

|May 13, 2026
MTMR4 variants have opposite gene-specific impact on life-threatening arrhythmic risk in type 1 and 2 long QT syndrome.

|May 11, 2026
Ventricular conduction is a marker for arrhythmic risk in SCN5A-E1784K overlap sodium channel disease.

|May 16, 2024
Long QT syndrome: importance of reassessing arrhythmic risk after treatment initiation.

Veronica Dusi, Federica Dagradi, Carla Spazzolini

|Aug 26, 2022
Spectrum of Rare and Common Genetic Variants in Arrhythmogenic Cardiomyopathy Patients.

Melania Lippi, Mattia Chiesa, Ciro Ascione

|Sep 10, 2021
Mutation location and IKs regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region.

Peter J Schwartz, Cristina Moreno, Maria-Christina Kotta

Pageof 2

Frequent Collaborators

5 joint publications

Federica Dagradi

5 joint publications

Lia Crotti

5 joint publications

Peter J Schwartz

4 joint publications

Carla Spazzolini